Obviously it's a perfect fit - it's not just about how much SB can make for somebody, but also what it is going to cost competitors such as Abbvie who will lose out on significant income as people move away from their product (Botox) and to SB. Of course there's also the option just to buy and not use SB, so as to protect their current products.
BOT - Anything but charting, page-5834
-
- There are more pages in this discussion • 3,438 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.020(5.26%) |
Mkt cap ! $660.6M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 37.5¢ | 35.0¢ | $2.355M | 6.482M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 666254 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 259571 | 17 |
View Market Depth
| Last trade - 12.46pm 15/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |